Exp Cell Res 316(16):26302643 Huang L, Kirschke CP, Lay YA, Levy LB, Lamirande DE, Zhang PH (2012) Znt7-null mice are more susceptible to diet-induced glucose intolerance and insulin resistance
Linsenbardt AJ, Breckenridge JM, Wilken GH, Macarthur H
11 The nonpeptide GLP-1 RA orforglipron (Foundayo) was approved in April 2026, becoming the second oral IBT available for chronic weight management
Article: My Peptide Protocol at 43: BPC-157, Tesamorelin, NAD+, and What Actually Changed My Peptide Protocol at 43: BPC-157, Tesamorelin, NAD+, and What Actually Changed I'm going to walk you through exactly what I take, why I take it, and what shifted in my body composition, recovery, and daily performance after integrating peptides into a system I'd already spent two decades building
Apr 2009;29(2):86-91